PFE  Pfizer Inc.

Exchange

NYSE

Sector

Consumer Durables

Industry

Major Pharmaceuticals

Market Cap.

194.55B

Vuru Grade

60.55/100

Current Price

$32.06
+0.36 (+1.14%)

Growth Price

$25.69
Overvalued by 19.88%

Stability Price

$11.98
Overvalued by 62.64%

Company Metrics

  • P/E 32.19
  • P/S 3.61
  • P/B 3.04
  • EPS 1
  • Cash ROIC 13.13%
  • Cash Ratio 0.79
  • Dividend 1.28 / 3.99%
  • Avg. Vol. 27.72M
  • Shares 6.07B
  • Market Cap. 194.55B

Company Description

Pfizer Inc., a biopharmaceutical company, offers prescription medicines for humans and animals worldwide. The company's Biopharmaceutical segment's provides Lipitor for elevated LDL-cholesterol levels in the blood; Enbrel for rheumatoid arthritis, polyarticular juvenile rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, and ankylosing spondylitis; Lyrica for post-herpetic neuralgia, diab... more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

Should Pfizer, Inc. Be on Your Stock Watchlist?
Motley Fool - Jan 17, 2017
Pfizer, Inc. (NYSE:PFE) is one of the largest drugmakers in the world, and management is making solid progress in kick-starting sales and profit growth following years of declining results tied to the loss of patent protection on Lipitor.
Pfizer CEO: This is what Trump doesn't understand about the pharma industry
CNBC - Jan 17, 2017
Ian Read, chairman and chief executive officer of Pfizer Inc., gestures as he speaks during a panel session at the World Economic Forum (WEF) in Davos, Switzerland, on Tuesday, Jan. 17, 2017.
Pfizer Inc. (PFE) Closes 0.22% Up on the Day for January 20
Equities.com - 6 hours ago
Shares of Pfizer Inc. (PFE) ended the trading day Friday at $31.77, representing a move of 0.22%, or $0.07 per share, on volume of 29.59 million shares.
The Pfizer, Inc. (PFE) Stake Reduced by Bank of Montreal Can - DailyQuint
Vetr Inc. Upgrades Pfizer, Inc. (PFE) to Strong-Buy - Sports Perspectives
Pfizer: 2 Risks Every Shareholder Should Be Aware Of
Seeking Alpha - Jan 16, 2017
However, investors should be cautious as they invest in the company, since its risk factor could be a reasonable explanation for why the shares trade at current levels.
Pfizer Inc. (PFE), Lockheed Martin (LMT) Get “Trumped”
Investorplace.com - Jan 11, 2017
U.S. equities are suffering another bout of volatility on Wednesday after intense fireworks were seen at president-elect Donald Trump's first press conference in months.
4 Reasons Why Pfizer Inc. Stock (PFE) Could be a Great Pick in 2017
Investorplace.com - Jan 4, 2017
Pfizer Inc. (PFE) is one of the most prominent names in the pharmaceutical sector, not just for its medicines and vaccines but also for its consumer healthcare products.
News Sentiment For Pfizer, Inc. (NYSE:PFE)
Markets Daily - 10 hours ago
Pfizer, Inc. (NYSE:PFE) has been given a sentiment score of 0.227 by research firm. Coming to the sentiment scale, the impact score measured on daily basis stands on a 1-100 scale.
Pfizer Inc. (NYSE:PFE) Challenges Businessmen To Come Up With Breast Cancer ...
Market Exclusive - Jan 10, 2017
Pfizer Inc. (NYSE:PFE) is stepping up its battle against breast cancer. Perhaps in an effort to help Ibrance sales, a top breast cancer treatment, the biopharma giant says that patients suffering from this incurable cancer are more often than not ...
Crazy Volume Spikes for: Pfizer Inc. (NYSE:PFE) - FactsReporter
Pfizer, Inc. (PFE) Receives $37.28 Consensus PT from Analysts - Sports Perspectives
Pfizer Inc. (NYSE:PFE) Agrees To Join Consortium To Efficient Transfer Of ...
Seneca Globe - 10 hours ago
Pfizer Inc. (NYSE:PFE) [Trend Analysis] shows fluctuation in active trade, on Friday shares reduced -1.03% to $31.70. The Milner Therapeutics Institute reported Pfizer Inc. (PFE) as a partner to the Milner Therapeutics Consortium. Pfizer has agreed to ...
Pfizer Agrees To Partner With Milner Therapeutics Institute - Market Exclusive
RNC Capital Management LLC Boosts Stake in Pfizer, Inc. (PFE)
The Cerbat Gem - Jan 7, 2017
Pfizer logo RNC Capital Management LLC raised its stake in Pfizer, Inc. (NYSE:PFE) by 2.6% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission.
Evermay Wealth Management LLC Boosts Position in Pfizer, Inc. (PFE) - Sports Perspectives
Stock On the Run: Pfizer Inc. (NYSE:PFE) - FactsReporter